AWM
AZN icon

Activest Wealth Management’s AstraZeneca AZN Stock Holding History

Activest Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18
Closed -$3.55K – 1350
2026
Q1 		$3.55K Hold
18
– – ﹤0.01% 878
2025
Q4 		$3.31K Buy
+18
New +$3.16K ﹤0.01% 823
2024
Q1 		– Hold
0
– – – 366
2021
Q3 		– Sell
-221
Closed -$26K – 387
2021
Q2 		$26K Hold
221
– – 0.02% 130
2021
Q1 		$22K Buy
+221
New +$22.2K 0.02% 141

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Activest Wealth Management's AZN Position: Q2 2026 in Review

Activest Wealth Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 18 shares — an estimated $3.55K sold.

Activest Wealth Management first reported a position in AZN in Q1 2021 and held it in 4 quarters. The position peaked at $26K in Q2 2021. 578 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Activest Wealth Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Activest Wealth Management sold 18 AstraZeneca shares in Q2 2026, an estimated $3.55K.
  • Activest Wealth Management first reported a position in AstraZeneca in Q1 2021 and held it in 4 quarters.
  • Activest Wealth Management's AstraZeneca position peaked at $26K in Q2 2021.
  • 578 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.